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Neurobiology of Disease
Small Heat Shock Proteins Induce a Cerebral Inflammatory
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More than 80%of Alzheimer’s disease (AD) patients have some degree of cerebral amyloid angiopathy (CAA). In addition to arteries and
veins, capillaries can also be affected. Capillary CAA (capCAA), rather than CAA in larger vessels, is associated with flame-like amyloid-
beta (A) deposits that may extend beyond the vessel wall and radiate into the neuropil, a phenomenon also known as “dyshoric
angiopathy.” A deposits in AD, parenchymal as well as (cap)CAA and dyshoric angiopathy, are associated with a local inflammatory
reaction, including activation of microglial cells and astrocytes that, among others, produce cytokines and reactive oxygen species. This
neuroinflammatory reactionmay account for at least part of the cognitive decline. In previous studies we observed that small heat shock
proteins (sHsps) are associated with A deposits in AD. In this study themolecular chaperones Hsp20, HspB8 andHspB2B3 were found
to colocalize with CAA and capCAA in AD brains. In addition, Hsp20, HspB8 and HspB2B3 colocalized with intercellular adhesion
molecule 1 (ICAM-1) in capCAA-associated dyshoric angiopathy. Furthermore, we demonstrated that Hsp20, HspB8 and HspB2B3
induced production of interleukin 8, soluble ICAM-1 andmonocyte chemoattractant protein 1 by human leptomeningeal smoothmuscle
cells and humanbrain astrocytes in vitro and thatHsp27 inhibited production of transforming growth factor beta 1 andCD40 ligand. Our
results suggest a central role for sHsps in the neuroinflammatory reaction in AD and CAA and thus in contributing to cognitive decline.
Introduction
In Alzheimer’s disease (AD) amyloid- (A) is deposited as
plaques in the parenchyma, but also as cerebral amyloid angiop-
athy (CAA) (Selkoe, 1991). Capillary A deposits (capCAA) cor-
relates with severity of AD pathology and clinical deterioration,
whereas larger vessel CAA does not (Attems and Jellinger, 2004;
Eurelings et al., 2010). Furthermore, in capCAA, flame-like A
deposits may extend beyond the vessel wall and radiate into the
neuropil, a phenomenon known as “dyshoric angiopathy” (At-
tems et al., 2011). Neuropathological examination of (cap)CAA
reveals activated microglia and astrocytes surrounding these le-
sions (McGeer and McGeer, 1995; Yamada et al., 1996; Akiyama
et al., 2000; Rozemuller et al., 2005; Richard et al., 2010; Attems et
al., 2011) and colocalization of inflammatory factors such as in-
tercellular adhesion molecule 1 (ICAM-1) (Verbeek et al., 1996).
In AD brains, an inflammatory reaction may occur in con-
junction with A deposits, characterized by the increased expres-
sion of, among others, transforming growth factor 1 (TGF-1)
(Wyss-Coray et al., 1997), interleukin (IL) 1, IL-8, monocyte
chemoattractant protein 1 (MCP-1), ICAM-1 and CD40 ligand
(Akiyama et al., 2000; Calingasan et al., 2002; Sokolova et al.,
2009;Heneka et al., 2010). This inflammatory reactionmay occur
in response to the presence of extracellular A or phagocytosis of
Adeposits bymicroglia (Malmet al., 2010). Inflammation, both
directly via interaction of activated glial cells and indirectly via
secreted neurotoxic mediators may compromise neuronal func-
tion. Indeed, transgenic mice with extensive CAA showed cogni-
tive decline as a result of increased microglial activation and
neuroinflammation (Xu et al., 2007), which could be reduced by
treatment with the anti-inflammatory drug minocycline, and
thereby improved cognition (Fan et al., 2007). Epidemiological
studies demonstrated that most patients with CAA-related in-
flammation show at least a partial clinical improvement to high
dose corticosteroids or other immunosuppressive agents (Chung
et al., 2011). Thus both human andmouse studies provide evidence
for a contribution of A to CAA-related neuroinflammation and
subsequent cognitive decline. However, the neuroinflammatory re-
action in AD patients may bemore complex.
In AD, several macromolecules colocalize with plaques and
CAA, including small heat shock proteins (sHsps) (Wilhelmus et
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al., 2006b,c). Previous research showed that expression of B-
crystallin and Hsp27 is increased in reactive astrocytes of AD
brains (Renkawek et al., 1993, 1994; Wilhelmus et al., 2006c).
Hsp20 codeposited with A in diffuse and classic plaques and
HspB2 with classic plaques and CAA (Wilhelmus et al., 2006c).
Moreover,HspB8 colocalizedwith classic plaques inADandwith
CAA in hereditary cerebral hemorrhage with amyloidosis of the
Dutch type (HCHWA-D) (Wilhelmus et al., 2006b). Further-
more, we observed that these sHsps, but not A, induced IL-6
production in various cerebral cell cultures (Wilhelmus et al.,
2009), suggesting that sHsps may play a pivotal role in inducing
neuroinflammation. Therefore, we investigated the association
of sHsps with (cap)CAA and CAA-associated inflammation in
postmortembrain and investigated the effect of selected sHsps on
the production of inflammatory factors by cultured human lep-
tomeningeal smooth muscle cells and astrocytes in vitro.
Materials andMethods
Reagents. Lyophilized A1–42 (95% pure) and A1–40 (98% pure) were
purchased from Quality Controlled Biochemicals. A with the “Dutch”
mutation (22 Glu3Gln, D-A1–40, 96% pure) was purchased from 21
st
Century Biochemicals. D-A1–40 was used as a model peptide, because it
causes CAA in hereditary cerebral hemorrhage with amyloidosis of the
Dutch type (HCHWA-D) (Davis andVanNostrand, 1996; Verbeek et al.,
1997; Wilhelmus et al., 2007). A1–42, A1–40, and D-A1–40 were dis-
solved in 1,1,1,3,3,3-hexafluoro-2 propanol (HFIP) (Sigma-Aldrich),
air-dried, and dissolved inDMSOat a concentration of 5mM. Aliquots of
the solutions were stored at80°C.
Autopsy material. Patient selection was based on neuropathological
findings at autopsy. Tissue samples were selected for the presence of
capCAA (Richard et al., 2010). For immunohistochemistry, tissue sam-
ples from the occipital neocortex from 3 AD patients with capCAA (age
76 12 years; postmortemdelay 5:53 2:09 h)were obtained after rapid
autopsy and immediately frozen in liquid nitrogen. Informed consent
was obtained according to European guidelines. Table 1 provides an
overview of the diagnosis, Braak stage, CERAD score, CAA grade, age,
postmortem interval (PMI) and gender. Neuropathological evaluation
was performed on frozen tissue from occipital pole cortex. CAA score
was defined as follows: severe (), moderate (), mild () as
previously described (Richard et al., 2010). Staging of AD was evaluated
according to the criteria established by Braak and Braak and CERAD
(Braak and Braak, 1991; Mirra et al., 1991).
Immunohistochemistry. In Table 2 the primary antibodies used in this
study are listed. Unless mentioned otherwise, we used biotin-labeled
horse anti-mouse antibodies (Vector Laboratories) as the detection an-
tibody for mouse monoclonal antibodies, or biotin-labeled goat-anti-
rabbit antibodies (Vector Laboratories) in the case of rabbit polyclonal
antibodies.
Serial cryosections (4 m) were air-dried and fixed in acetone for 5
min. Endogenous peroxidase activity was blocked using acetone contain-
ing 0.15% H2O2 for 5 min. Sections were preincubated for 30 min with
20% animal serum, the type of which was determined by the specific
biotin-labeled antibody used. Subsequently, sections were incubated
overnight at 4°C with primary antibody (Table 2), with secondary anti-
bodies for 60min at room temperature, and with the avidin-biotin com-
plex according to the manufacturer’s description. Between incubation
steps, sections were extensively washed using PBS. 3-Amino-9-ethyl car-
bazole (AEC) was used as a chromogen. After a short rinse in tap water
the preparations were incubated with hematoxylin for 1 min and thor-
oughly washedwith tap water for 10min. Finally, sections weremounted
with Imsol mount (Klinipath). All antibodies were diluted in PBS con-
taining 1% bovine serum albumin (BSA), which also served as a negative
control. At regular intervals, sections were stained with anti-A to allow
for topographical alignment of CAAwith the stains for sHps and inflam-
matory factors.
For double immunostaining of A and/or astrocytes/microglia, sec-
tions were stained using the EnVision method as previously described
(Richard et al., 2010). Briefly, sections were incubated overnight at 4°C
with primary antibodies (Table 2), followed by incubationwith EnVision
HRP. EnVision 3,3-diaminobenzidine (DAB) was used as chromogen.
Antibodies were diluted in PBS/1% BSA, which also served as a negative
control. After each incubation, slides were extensively washed with PBS.
For the detection of fibrillar A in plaques and CAA, sections were
stained with Congo Red (0.5% in Ethanol 80%, 3% NaCl) for 20 min at
room temperature. Finally, sections were mounted with DePeX mount-
ing medium Gurr.
Expression and purification of recombinant proteins. Recombinant hu-
man B-crystallin and HspB2B3 were expressed and purified as de-
scribed previously (Wilhelmus et al., 2006a). Since it was demonstrated
that HspB2 andHspB3 form functional heterogeneous complexes of 150
kDa (Sugiyama et al., 2000), both proteinswere expressed together in one
vector. Coding sequences for the following sHsps were ligated into the
pET-46 Ek/LIC vector which also introduces a N-terminal His-tag
sequence (Novagen, Merck Chemicals Ltd): human Hsp27, human
Hsp20, and human HspB8. Hsp20 and HspB8 were expressed in
Rosetta(DE3)pLysS competent cells (Novagen). Hsp27 was expressed in
its BL21(DE3)pLysS competent cells (Novagen). A culture inoculated
from a single colony was induced by addition of 0.25mM isopropyl-thio-
-D-galactopyranoside (IPTG) for 4 h at 37°C, with the exception of
Hsp20, which was induced for 16 h at 25°C. After incubation with IPTG,
cells were harvested and lysed by sonication in native lysis buffer (NLB;
50 mMNaH2PO4, 300 mMNaCl, pH 8.0) supplemented with EDTA-free
protease inhibitor (Roche Applied Science). Insoluble proteins were re-
moved by centrifugation. All sHsps were purified over a Ni-NTA agarose
Table 1. Overview of the origin of astrocyte and HBP cell cultures and tissue
sections
Number Diagnosis
Age
(years)
PMI
(h:m) Gender
NFT stage
(Braak)
Plaque
score
(CERAD)
CAA
grade Cell type
Cell culture
1 AD 84 6:30 F V C N.D. Astrocyte
2 AD 92 7:00 F V 0 N.D. Astrocyte
3 Control 76 4:40 F I B N.D. Astrocyte
4 AD 77 3:00 M VI C  SMC
5 Parkinson 91 4:00 F V C  SMC
6 Control 83 4:00 F III B  SMC
IHC
7 AD CAA 65 7:20 M V C  N.A.
8 AD CAA 89 6:55 F V C  N.A.
9 AD CAA 74 3:25 M VI C  N.A.
10 Control 81 3:45 M I 0  N.A.
11 Control 71 6:05 F III C  N.A.
12 Control 92 6:25 F III A  N.A.
Overview of the cases used in this study. IHC, Tissue used for immunohistochemistry; F, female; M, male; N.D., not
determined; N.A., not applicable. Grading of AD (Braak scores) was performed as described in Materials and
Methods.
Table 2. Primary antibodies used in this study
Primary
antibody Antigen
Species
raised in Dilution Source (reference)
6C6 A Mouse 1:250 Dr. Schenk, Elan Pharmaceuticals
GFAP GFAP Mouse 1:10 Monosan, Sanbio
LN3 HLA-DR Mouse 1:50 eBioscience
MAB208 IL-8 Mouse 1:100 R&D Systems
LS-C8642 MCP-1 Mouse 1:100 Lifespan Biosciences
CL203 ICAM-1 Mouse 1:500 (Verbeek et al., 1994a)
PN-E12 ICAM-1 Mouse 1:25 (Verbeek et al., 1994a)
Pab-aBcr B-Crystallin Rabbit 1:500 (den Engelsman et al., 2003)
1426 Hsp27 Rabbit 1:2000 Abcam
VDK-p20 Hsp20 Rabbit 1:4000 (van de Klundert et al., 1998)
J92 HspB8 Rabbit 1:2000 (Verschuure et al., 2003)
F34 HspB2 Rabbit 1:2000 (Verschuure et al., 2003)
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column (Qiagen) using NLB supplemented with increasing concentra-
tions of imidazole (Sigma-Aldrich Chemie BV) ranging from 20 up to
250 mM. After desalting, sHsps were concentrated in 10 mM Tris, 50 mM
NaCl, pH 7.4 buffer by using an iCON concentrator spin column
(Thermo Fisher Scientific Inc.). Protein concentration was determined
using a BCA Protein Assay kit according to the manufacturer’s descrip-
tion (Thermo Fisher Scientific). Purified sHsps were aliquoted and
stored at 80°C. Purity of the preparations was95%.
Cell culture. Smooth muscle cells (SMCs) and astrocytes were both
isolated from human brain tissue obtained after rapid autopsy, as de-
scribed previously (De Groot et al., 1997; Verbeek et al., 1994b; Veerhuis
et al., 1998) (Table 1). Diagnosis and grading of patients was performed
according to the criteria mentioned previously. SMCs were maintained
in Eagle’s modification of essential medium (EMEM; PAA Laboratories
GmbH), supplemented with 10% human serum (Lonza BioWhittaker
Benelux BV), 20% fetal bovine serum (PAA Laboratories GmbH), re-
combinant basic fibroblast growth factor (1 ng/ml) and gentamycin (2.5
g/ml). Astrocytes were maintained in a mixture (1:1 v/v) of DMEM
and Ham’s F10 supplemented with 10% fetal bovine serum, 2 mM
L-glutamine (Cambrex) and gentamycin (2.5 g/ml). All primary cell
cultures were cultured at 37°C, 5% CO2 and 90% relative humidity.
Although the cultured astrocytes and SMCs were derived from different
clinical backgrounds (i.e., either AD or control patients), we did not
observe differences with respect to their responses in the various types of
experiments.
Cell passages 3–9 were used for the experiments. Control cells incu-
bated with EMEM or DMEM/Ham’s F10 and 0.1% BSA (serum-free
medium) demonstrated normal morphology. Experiments were per-
formed at least twice.
ELISA.Duplicate wells (12-well plate; Corning Inc) with cultured cells
were preincubated with serum-free medium for a minimum of 4 h. Sub-
sequently, cells were incubated with 12.5 M synthetic A1–40, A1–42,
D-A1–40 or 12.5 M purified sHsps (B-crystallin, Hsp27, Hsp20,
HspB8 and HspB2B3) at 37°C and 5% CO2. This concentration was the
lowest concentration to induce a significant effect across all sHsps tested.
In addition, the same concentration of A induced biological effects in
cultured SMCs and astrocytes (Verbeek et al., 1997; Bruinsma et al.,
2010) and was therefore chosen in the experiments. Lipopolysaccharide
(LPS; 055:B5; Sigma-Aldrich) stimulation (1 g/ml) was used as a
positive control for inducing cytokine production. After 48 h of in-
cubation, supernatants and cell lysates (solubilized in RIPA; 50mMTris
HCl, pH7.4, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, and 0.1% SDS in Milli-Q) were collected, centrifuged at 13.200
rpm for 10 min at 4°C and stored at80°C until further use. To exclude
endotoxin contamination, potentially present in the purified sHsp
samples, coincubation with polymixin B (PMB; Sigma-Aldrich; 10 g/
ml) was used to inhibit LPS-mediated inflammation. In these experi-
ments, PMBwas preincubated with both the LPS and the sHsps for 1 h at
37°C before addition to the cells.
Il-8, ICAM-1, MCP-1, CD40 ligand, and TGF-1 levels in cell culture
supernatantweremeasured using commercial enzyme immunoassay kits
according to the manufacturer’s instructions (DuoSet ELISA, R&D Sys-
tems). To correct for differences in cell density, inflammatory factor
production was normalized to protein content of the cell lysate which
was determined by using a BCA Protein Assay kit according to the man-
ufacturer’s description (Thermo Fisher Scientific Inc.). Concentrations
of the various inflammatory factors were expressed as pg/mg protein.
Statistical analysis. Statistical analyses were performed using an inde-
pendent sample t test in SPSS 14.0 for Windows software. Statistical
significance was set at p 0.05.
Results
Inflammatory cells in AD brains with severe CAA pathology,
capCAA, and dyshoric angiopathy
Double staining forGFAP andCongo red demonstrated the pres-
ence of astrocytes around A-laden vessels, with a more promi-
nentGFAPstainingaround the largervessels (Fig. 1A,C).Clustersof
HLA-DR-positive microglia were also observed around larger ves-
sels and capillaries laden with A and were particularly prominent
around the capillaries (Fig. 1B,D).
Expression of sHsps in AD brains with severe CAA pathology,
capCAA, and dyshoric angiopathy
In control brains,B-crystallin stainingwas observed in glial cells
(Fig. 2B). Furthermore, leptomeningeal vessels as well as a few
astrocytes in the whitematter were also stained (data not shown).
Hsp27 staining in control brains was limited to leptomeningeal
vessels (data not shown), but not observed in parenchymal ves-
sels (Fig. 2D). Hsp20 staining in control brains was occasionally
observed in astrocytes in white and graymatter (data not shown).
Weak immunoreactivity of Hsp20 was also observed in large pa-
renchymal (Fig. 2F, open arrow) and leptomeningeal vessels
(data not shown). HspB8 staining in control brains was observed
in astrocytes in both gray and white matter (Fig. 2H, arrow) and
in cerebrovascular cells of large parenchymal vessels (Fig. 2H,
open arrow). Furthermore, weak staining for HspB2 was ob-
served in cerebrovascular cells in large parenchymal vessels (Fig.
2 J, open arrow) and in an occasional astrocyte or microglial cell
in the brain parenchyma (data not shown). IL-8 (Fig. 2L) and
MCP-1 (Fig. 2P) staining was not observed in normal parenchy-
mal or leptomeningeal vessels in control brains, whereas ICAM-1
staining was observed in endothelial cells in control brains (Fig.
2N, arrow).
In AD brains with severe (cap)CAA pathology, the anti-A
antibody (6C6) stained A-affected vessels and capillaries (Fig.
3A,B). In addition, dyshoric angiopathy (Fig. 3A) was often ob-
served. The antibodies directed against B-crystallin, Hsp27,
Hsp20, HspB8 and HspB2 showed different staining patterns for
these sHsps in CAA, capCAA and dyshoric angiopathy. Repre-
sentative staining results are shown in Figure 3 and a summary of
the immunohistochemical results is shown in Table 3. Anti-B-
crystallin antibody stained reactive astrocytes and activated mi-
croglia associated with CAA (Fig. 3C) and capCAA (Fig. 3D).
Hsp27 staining was not observed in gray matter (Fig. 3E,F), but
was occasionally observed in reactive astrocytes and microglia in
Figure 1. Immunohistochemical staining of GFAP (A, C) and microglial cell marker (LN3; B,
D) in CAA (A, B) and capCAA (C, D). All sections are double stained with Congo Red. GFAP-
positive reactive astrocytes are present around both larger vessels and capillaries (A, C). Micro-
glial activation is associated with both large vessels and capillaries, however more prominent
around the latter (B, D).
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the white matter (data not shown). In addition, reactive astro-
cytes surrounding CAA were immunopositive for Hsp20 (Fig.
3G) and occasionally Hsp-20-positive reactive astrocytes were
observed surrounding capCAA (data not shown). Anti-HspB8
stained reactive astrocytes and microglia in both white and gray
matter and occasionally immunoreactivity of HspB2 was ob-
served with reactive astrocytes and microglia. Whereas HspB2
(Fig. 3L) colocalized with A in capCAA and CAA, no immuno-
staining for B-crystallin (Fig. 3C,D), Hsp27 (Fig. 3E,F), Hsp20
(Fig. 3G,H) and HspB8 (Fig. 3 I, J) was observed. Furthermore,
colocalization of Hsp20 (Fig. 3G), HspB8 (Fig. 3I) and HspB2
(Fig. 3K), but not of B-crystallin (Fig. 3C) and Hsp27 (Fig. 3E),
with A surrounding CAA and capCAA (dyshoric angiopathy)
was observed.
Expression of inflammatory factors in AD brains with severe
CAA pathology, capCAA, and dyshoric angiopathy
ICAM-1 was associated with dyshoric A deposits surrounding
CAA and capCAA, but not with the A deposits within the vessel
wall (Fig. 3O,P), suggesting colocalization of Hsp20, HspB8
and HspB2 with ICAM-1 in dyshoric angiopathy near (cap)CAA.
Although ICAM-1 has also been detected in a soluble form
(Harning et al., 1991; Rothlein et al., 1991), it is mainly described
as a membrane-bound cell adhesion molecule. Therefore, the
ICAM-1 staining we observed is very likely due to membrane-
bound ICAM-1. In earlier studies an increase in IL-8 andMCP-1
in AD brains was observed after soluble protein extraction of
human brain lysates or in paraffin-embedded formalin-fixed tis-
sue (Akiyama et al., 2000; Calingasan et al., 2002; Sokolova et al.,
2009). In the present study, no IL-8 andMCP-1 was detectable in
tissue from AD patients with severe CAA pathology (Fig.
3M,N,Q,R). In cryosections, these soluble factors might escape de-
tection due tomild fixation of the tissue.
sHsps induce the production of inflammatory factors by
human leptomeningeal smoothmuscle cells and human brain
astrocytes
Our immunohistochemical studies suggest that both A and
sHsps accumulate in or near (cap)CAA, where an inflammatory
reaction is observed as well. Since human leptomeningeal SMCs
are already early affected by A in CAA (Vinters et al., 1996), we
studied whether A or sHsps were able to induce production of
cytokines and other inflammatory factors by cultured SMCs. In
addition, since reactive astrocytes colocalize near (cap)CAA (Fig.
1), we also studied the potential of A and sHsps to induce an
inflammatory reaction in human brain astrocytes.
Neither A1–40, A1–42, nor D-A1–40 (12.5M) induced pro-
duction of IL-8, ICAM-1, MCP-1, TGF-1 or CD40 ligand by
SMCs or astrocytes, above control levels (Figs. 4, 5). Incubation
of 1 g/ml LPS induced IL-8 production (Fig. 4A; p  0.05) by
SMCs, but not production of soluble ICAM-1 (sICAM-1; Fig.
Figure 2. Immunohistochemical staining of A (A, C, E, G, I, K,M, O), sHsps (B, D, F, H, J;
open arrow), and inflammatory factors (L, N, P; open arrow) in or near normal vessels in the
occipital cortex of control patients. Serial sections: A, B; C, D; E, F; G, H; I, J; K, L; M, N; O, P.
Anti-B-crystallin antibodies stained glial cells throughout the cortex (B, arrow). Anti-Hsp27
4
antibodies were only occasionally immunoreactive with leptomeningeal vessels (data not
shown), but not with parenchymal vessels (D). Hsp20 was occasionally demonstrated in astro-
cytes in normal brains (data not shown).Weak immunoreactivity of Hsp20was also observed in
largeparenchymal (F, openarrow)and leptomeningeal vessels. HspB8 stainingwasobserved in
astrocytes in both gray andwhitematter (H, arrow) and in cerebrovascular cells of large paren-
chymal vessels (H, open arrow).Weak staining for HspB2was observed in cerebrovascular cells
in large parenchymal vessels (J, open arrow) and in an occasional astrocyte or microglial cell in
thebrainparenchyma (datanot shown). Furthermore, anti-IL-8 (L) andanti-MCP-1 (P) staining
was absent from normal parenchymal or leptomeningeal vessels. The anti-ICAM antibodies
stained endothelial cells (N, arrow). Original magnification 200.
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4B), MCP-1 (Fig. 4C) and TGF-1 (Fig.
4D). Furthermore, incubation of 1 g/ml
LPS induced IL-8 (Fig. 5A; p  0.01),
sICAM-1 (Fig. 5B; p  0.01) and MCP-1
(Fig. 5C; p  0.05) production by astro-
cytes, but not production of TGF-1 (Fig.
5D) and CD40 ligand (Fig. 5E). After pre-
incubation and coincubation of LPS with
PMB, production of inflammatory factors
by SMCs and astrocytes returned to con-
trol levels (Fig. 5; p  0.05), indicating
that PMB efficiently inhibited the LPS-
induced inflammatory reaction.
Incubation of SMCs with 12.5 M
Hsp20, HspB8 or HspB2B3 resulted in a
strong inductionof IL-8 (Fig. 4A;p 0.01),
sICAM-1 (Fig. 4B; Hsp20, HspB2B3, p 
0.001; HspB8, p  0.01) and MCP-1 (Fig.
4C; Hsp20, HspB2B3, p  0.001; HspB8,
p 0.01) secretion, but not of TGF-1 (Fig.
4D). In contrast to the increased levels of
IL-8 production after incubation with 12.5
M Hsp27 (Fig. 4A; p  0.001), decreased
( p  0.01) TGF-1 production was ob-
served after Hsp27 treatment compared
with control (Fig. 4D). In addition, incu-
bationwithHsp27 did not induce levels of
sICAM-1 (Fig. 4B) and MCP-1 (Fig. 4C)
above control levels in SMCs. Further-
more, SMCs did not seem to secrete CD40
ligand, since after incubation of these cells
with either A1–40, A1–42, and D-A1–40
or sHsps, the concentrations of CD40 li-
gand remained below the detection level
(data not shown).
Incubation of astrocytes with 12.5 M
Hsp20,HspB8orHspB2B3alsoresulted ina
strong induction of IL-8 (Fig. 5A; p 
0.001), sICAM-1 (Fig. 5B; p  0.001) and
MCP-1 (Fig. 5C; p  0.001) secretion, but
not of TGF-1 (Fig. 5D). In addition, only
12.5 M HspB8 and HspB2B3 induced
CD40 ligand production by astrocytes (Fig.
5E; p  0.05 and p  0.01 respectively).
Comparable to the effects of Hsp27 in
SMCs, IL-8 production by astrocytes was also increased after incu-
bation with 12.5 M Hsp27 (Fig. 5A; p  0.01), however, Hsp27
induced adecrease in theproductionofTGF-1 (Fig. 5D;p0.001)
and CD40 ligand (Fig. 5E; p  0.01) compared with control. Fur-
thermore, incubationwithHsp27didnot result in levelsof sICAM-1
(Fig. 5B) andMCP-1 (Fig. 5C) above control levels in astrocytes.
To exclude LPS contamination, potentially present in the pu-
rified sHsp samples, we coincubated cell samples with PMB and
sHsps to inhibit potential LPS-mediated inflammation. After
preincubation and coincubation of LPSwith PMB, production of
inflammatory factors by SMCs and astrocytes returned to control
levels (Fig. 6A,B; p  0.05), indicating that PMB efficiently in-
hibited the LPS-induced inflammatory reaction. Whereas 12.5
M B-crystallin seemed to induce IL-8 secretion by SMCs and
astrocytes, this effect was completely abolished by preincubation
and coincubation with PMB (Fig. 6A,B; p 0.05), indicating that
tracesofLPS in theB-crystallinpreparations are responsible for the
observed effects. In contrast, PMB had no, or only aminimal effect,
on the production levels of IL-8 by SMCs and astrocytes induced
by the other sHsps samples (Fig. 6A,B), suggesting a strong
inducing effect of these sHsps on cytokine production.
Discussion
Themain findings of this study are as follows: 1)Hsp20,HspB8 and
HspB2 are associated with (cap)CAA and dyshoric angiopathy in
AD brains with severe CAA pathology; 2) these sHsps colocalize
Figure3. Immunohistochemical staining of sHsps and inflammatory factors in or near CAA vessels (A, C,E,G, I,K,M,O,Q; serial
sections) and capCAA (B,D, F,H, J, L,N,P,R; serial sections; arrows indicate the same capillary in each panel to serve as a reference
to allowoptimal comparisonwithother panels) in theoccipital cortex ofADbrains. Theanti-Aantibody6C6 stainedCAA, capCAA,
and dyshoric angiopathy in AD brains (A, B; to allow optimal comparison with other stains, these panels are shown twice). Both
anti-B-crystallin (C, D) and anti-Hsp27 (E, F) antibody staining was absent in A deposits. No anti-Hsp20 and anti-HspB8
staining was observed in CAA and capCAA; however, colocalization of Hsp20 and HspB8 (G, H; I, J) with dyshoric angiopathy (A
surrounding CAA)was observed. The presence of HspB2 in CAA (K) and capCAA (L) of AD brainswith severe CAAwas observed, but
also colocalization of HspB2 with dyshoric angiopathy (K) was observed. The anti-B-crystallin (C), anti-Hsp20 (G), and anti-
HspB8 antibodies (I) stained reactive astrocytes andmicroglia associatedwith CAA. Occasionally, immunoreactivity of HspB2with
reactive astrocytes and microglia was observed. Furthermore, anti-IL-8 (M, N, arrow) and anti-MCP-1 (Q, R, arrow) staining was
absent from CAA and capCAA vessels. In addition, ICAM-1was associated with dyshoric angiopathy, but not with the A deposits
in the vessel wall (O, P, arrow; inset, ICAM-1 staining (left) and A staining (right) of another capCAA vessel). Original magnifi-
cation 200.
Table 3. Summary of the immunohistochemical results
capCAA CAA Dyshoric angiopathy
B-crystallin 0% 0% 0%
Hsp27 0% 0% 0%
Hsp20 10% 0% 90%
HspB8 10% 0% 100%
HspB2 80% 100% 95%
Quantification of the percentages of A deposits that are stained by the sHsp antibodies in all patients (average of
n 3 patients).
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with ICAM-1 in dyshoric angiopathy near (cap)CAA; 3) sHsps
(especially Hsp20, HspB8 and HspB2B3), but not A, increased
secretion of IL-8, sICAM-1 and MCP-1 by cultured human lep-
tomeningeal SMCs and human brain astrocytes; 4) Hsp27 re-
duced secretion of TGF-1 by SMCs and astrocytes and CD40
ligand secretion by astrocytes.
The observed astrocytic and microglial activation, indicative
of an inflammatory reaction, around (cap)CAA in this report is in
line with earlier studies (Richard et al., 2010; Attems et al., 2011).
In addition, colocalization of Hsp20, HspB8 and HspB2, but
not B-crystallin and Hsp27, with (cap)CAA and dyshoric angi-
opathy near (cap)CAA is also in line with our previous studies in
which colocalization of these sHsps was found with CAA and/or
parenchymal deposits of A (Wilhelmus et al., 2006b,c, 2009). It
has been suggested that Hsp20, HspB8 and HspB2 are predomi-
nantly associated with fibrillar A in vivo (Wilhelmus et al.,
2006b,c, 2009) and our results suggest a similar association of
these sHsps with fibrillar A in (cap)CAA and with dyshoric
angiopathy near (cap)CAA. Thus, Hsp20, HspB8 and HspB2 are
clearly associatedwith various types ofAdeposits inADbrains and
may participate in the local inflammatory reaction.
CAA-related inflammation is of clinical importance since pa-
tients with this type of pathology present with cognitive decline,
seizures and headaches, that improve upon anti-inflammatory
treatment (Eng et al., 2004; Kinnecom et al., 2007; Chung et al.,
2011). In addition, it has been suggested that especially capCAA
with spreading of the A deposits into the neuropil could con-
tribute to a rapid clinical deterioration (Eurelings et al., 2010),
suggesting an important role of capCAA and dyshoric angiopa-
thy, rather than plaques andCAA, in cognitive decline. InAD,A
has been shown to trigger neuroinflammation by e.g., activation
of the complement system (Heneka et al., 2010), and activation of
microglia and astrocytes (Tan et al., 1999;
Heneka et al., 2010). In addition, the pro-
inflammatory factors IL-8, MCP-1 and
CD40 ligand are increased in AD
(Akiyama et al., 2000; Calingasan et al.,
2002; Sokolova et al., 2009) and ICAM-1
and TGF-1 colocalize with A deposits
(Verbeek et al., 1996; Wyss-Coray et al.,
1997), suggesting that Amay induce the
expression of these inflammatory factors.
In contrast, however, the results of the
present study suggest that sHsps may be
much more potent inducers of an inflam-
matory reaction in AD brains than A.
Interestingly, the proinflammatory effect
of these sHsps does not seem to be limited
to a single parameter such as IL-6 (Wil-
helmus et al., 2009), but includesmultiple
inflammatory factors that are observed in
vivo. We obtained in vivo evidence for the
colocalization of sHsps near sites of A-
associated inflammation in the cerebral
vasculature and demonstrated in vitro
thatHsp20,HspB8 andHspB2B3 induced
production and secretion of IL-8, MCP-1
and sICAM-1 in SMCs and astrocytes,
with little or no effect of Hsp27 and no
effect of B-crystallin on these factors.
These results are in line with, and extend,
our previous findings that sHsps may be
among the key mediators of the inflam-
matory reactions associated with (cap)CAA, since they also in-
duced IL-6 production in cultured SMCs, astrocytes and
microglia (Wilhelmus et al., 2009). Interestingly, our results sug-
gest that those sHsps that occur extracellularly in plaques or
dyshoric angiopathy and (cap)CAA (i.e., Hsp20, HspB8 and
HspB2B3) have a potent proinflammatory effect, indicating that
especially these sHsps are important in the inflammatory reac-
tion in CAA. Interestingly, HspB8 and HspB2B3 induced CD40
ligand expression in astrocytes, but not in SMCs, suggesting that
the reported upregulation of CD40 ligand in AD (van der Wal et
al., 1993; Calingasan et al., 2002) might be due to astrocytic pro-
duction. In contrast to these findings, however, Hsp20, HspB8
and HspB2B3 did not induce production of TGF-1 in both
SMCs and astrocytes, although these factors are also reported to
be upregulated in AD (van der Wal et al., 1993; Calingasan et al.,
2002). This suggests that this cytokine might be upregulated by
alternative mechanisms or cell types.
Hsp27 is amember of the sHsp family with remarkable capac-
ities compared with the other sHsps tested in this study. Hsp27
was able to induce IL-8 and inhibit TGF-1 production in both
human SMCs and astrocytes in vitro. Furthermore, Hsp27 inhib-
ited CD40 ligand production in astrocytes. Interestingly, IL-8 is a
proinflammatory cytokine and TGF-1 can act as an anti-
inflammatory factor by inhibition of local inflammation result-
ing in reduced tissue injury that may occur as a response to
inflammation (Wahl, 1992). Furthermore, the interaction of
CD40 ligand with its receptor has been implicated in the modu-
lation of anti-inflammatory responses (Liu et al., 2010). Thus,
Hsp27 may exert a proinflammatory effect, both through induc-
ing a proinflammatory reaction (e.g., IL-8) and reducing the pro-
duction of the anti-inflammatory factors (e.g., CD40 ligand and
TGF-1) (Liu et al., 2010). In addition, Hsp27 may also function
Figure 4. Production of inflammatory factors by human brain leptomeningeal SMCs. Cultured SMCs were incubated with 12.5
M D-A40, A42, A40, Hsp27, Hsp20, HspB8, HspB2B3, or 1g/ml LPS for 2 d at 37°C. Supernatant was collected and IL-8 (A),
sICAM-1 (B), MCP-1 (C), and TGF-1 (D) concentrations were measured using ELISA. Statistical analysis was performed using an
independent sample t test. The level of significance of the difference compared with control is indicated as follows: *p 0.05;
**p 0.01; ***p 0.001; p 0.05 is not indicated. Means SEM are shown.
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as an indirect anti-apoptotic molecule
(Concannon et al., 2003) by inhibiting the
proapoptotic proteins caspase-3 (Stetler
et al., 2009) and Bax (Havasi et al., 2008).
Since both TGF-1 and CD40 ligand may
be involved in apoptosis during inflam-
mation (Calingasan et al., 2002; Schuster
and Krieglstein, 2002), reduced TGF1
and CD40 ligand levels induced by Hsp27
may add to the anti-apoptotic effect of
Hsp27. Furthermore, in transgenic mice
models for AD it has been demonstrated
that TGF-1 overexpression may lead to
A deposits in cerebral blood vessels and
meningeal vessels (Wyss-Coray et al.,
1997). Moreover, elevated levels of CD40
ligand may lead to endothelial dysfunc-
tion and atherothrombosis, whereas inhi-
bition of CD40/CD40 ligand interaction
may prevent atherogenesis in animal models (Urbich and Dim-
meler, 2004; Chakrabarti et al., 2010; Dominguez-Rodriguez et
al., 2010; Yoshioka et al., 2010). Thus, since Hsp27 affects the
expression of TGF-1 and CD40 ligand, Hsp27may create a proin-
flammatory environment, likely both by reducing the production
of anti-inflammatory factors and inducing production of
proinflammatory cytokines, inhibit apoptotic processes and
may alter the vascular micro-environment. However, more
study is required to elucidate the exact role of Hsp27 in neu-
rovascular inflammation in AD.
It has been suggested that A itself can induce neuroinflam-
mation (Heneka et al., 2010). In our study, however, A1–40,
A1–42, and D-A1–40 had no effect on the production of inflam-
matory factors by SMCs and astrocytes. Previously, we also
demonstrated that A did not induce IL-6 production by cere-
brovascular cells and astrocytes (Wilhelmus et al., 2009). How-
ever, in the same study it was shown that A slightly induced IL-6
production by microglia (Wilhelmus et al., 2009). In addition, in
another study dose-dependent increases of IL-8 andMCP-1 pro-
duction by human brain microglia were observed after exposure
to A (Lue et al., 2001). Together, these studies suggest that in the
brain, microglial cells may be particularly susceptible to A, re-
sulting in an inflammatory reaction, but that other cerebral cell
types, such as vascular cells and astrocytes, do not respond to A
in a proinflammatory way, but may be stimulated to do so by
sHsps.
Figure 5. Production of inflammatory factors by human brain astrocytes. Cultured astrocyteswere incubatedwith 12.5M D-A40, A42, A40, Hsp27, Hsp20, HspB8, HspB2B3, or 1g/ml LPS
for 2 d at 37°C. Supernatantwas collected and IL-8 (A), sICAM-1 (B),MCP-1 (C), TGF-1 (D), and CD40 ligand (E) concentrationsweremeasured using ELISA. Statistical analysiswas performed using
an independent sample t test. The level of significance of the difference compared with control is indicated as follows: *p 0.05; **p 0.01; ***p 0.001; p 0.05 is not indicated. Means
SEM are shown.
Figure 6. Production of IL-8 by human brain leptomeningeal SMCs (A) and human brain astrocytes (B) after coincubationwith PMB.
Culturedcellswere coincubatedwith1g/mlLPSora12.5Mconcentrationof the indicatedsHspwithorwithout10g/mlPMBfor2d
at 37°C. In these experiments, PMB was preincubated with both the LPS and the sHsps for 1 h at 37°C before addition to the cells.
Supernatant was collected and IL-8 concentrations were measured using ELISA. PMB efficiently abolished the effects of LPS and B-
crystallinon IL-8production,butnotof theother sHsps. Statistical analysiswasperformedusingan independent sample t test. The level of
significanceofthedifferencecomparedwithcontrol is indicatedasfollows:*p0.05;p0.05isnot indicated.MeansSEMareshown.
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In conclusion, Hsp20, HspB8 and HspB2 are associated with
(cap)CAA and dyshoric angiopathy in AD brains with severe
CAA pathology. In addition, colocalization of these sHsps with
ICAM-1 around A-laden vessels was observed. Furthermore,
we demonstrated that Hsp20, HspB8 and HspB2B3 induced the
production of inflammatory factors in vitro, suggesting that these
sHsps might be among the key mediators of the inflammatory
reactions associated with (cap)CAA and dyshoric angiopathy. An
interesting role for Hsp27 was found, since this sHsp seems to
induce a proinflammatory effect by reducing the normal anti-
inflammatory effect in human SMC and astrocytes in vitro. Fur-
thermore, although it has been suggested thatA itself can induce
inflammation (Heneka et al., 2010), we did not observe such an
effect in cultured SMCs and astrocytes. The results of this study
provide new insights in the inflammatory reactions associated
with AD and CAA and, therefore, might provide interesting new
targets for therapeutic intervention in the pathogenesis of AD
and CAA.
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